In this context, our results are in accordance with the work by Robbins et al, which demonstrated that the effectiveness of PD-L1–CAR-bearing effector cells can be significantly amplified following the preincubation of cancer cells with IFNγ.7 The gene discussed is IFNG; the disease is cancer.